Delhi, March 17, 2025 (GLOBE NEWSWIRE) -- Global Transdermal Patch Market Opportunity, Patch Dosage, Price & Clinical Trials Insight 2030 Report Highlights & Findings: The global market for ...

Fact checked by Jennifer Klump Key Takeaways The FDA has removed the black box warning on hormone therapy, which had ...

United States The type of adhesive patches known as transdermal patches is therapeutic. By utilizing transdermal technology and the diffusion technique, they assist in delivering a predetermined dose ...

A timely 2026 release highlighting growing consumer research interest in skin-absorption wellness formats, ingredient themes, product variety, and publicly visible brand information across the Gentle ...

Don't blame a menopause fad. There is little incentive for pharmacy companies to ensure smooth, consistent access.

The growing interest in transdermal delivery as a metabolic support is reflected in Purisaki Berberine Patches. They are said ...

Credit: Alvogen, Inc. Fentanyl is an opioid agonist indicated for the management of severe or persistent pain in opioid-tolerant patients. At this time, Alvogen Inc has received 1 serious adverse ...

Credit: Shutterstock. Adlarity is a once-weekly transdermal formulation of donepezil that is designed to be worn for 7 days with consistent adhesion. The Food and Drug Administration (FDA) has ...

Restless legs syndrome (RLS) is a chronic, usually idiopathic disorder characterized by uncontrollable urges to move the legs or arms at night along with unpleasant sensations in the affected limbs.

The US Food and Drug Administration (FDA) has approved donepezil transdermal system (Adlarity) for patients with mild, moderate, or severe Alzheimer's disease (AD), the manufacturer has announced.